Carlyle Group Inc.
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 8, 2026), Carlyle Group Inc. reported 20 stock positions worth $10.6 billion. Its top holding was Medline Class A (MDLN) at 78.4% of the portfolio, followed by Standardaero (SARO, 20.6%) and Phathom Pharmaceuticals (PHAT, 0.4%). Compared with Q4 2025, it opened 1 new position, sold out of 1 and reduced 2. The biggest buy was a new position in Heartflow (HTFL) and the biggest sale Standardaero (SARO, shares −45%).
- Most Recent 13F
- Q2 2026
- Location
- WASHINGTON, DC
- CIK
- 0001527166
- Portfolio Value
- $10.6B (Q1 2026)
- SEC Filing
- 0000898432-26-000339 ↗ filed May 8, 2026
Holdings Value
Holdings 20 stocks · $10.6B
| MDLN Medline Inc. Class A | 78.40% | 187,083,713 | $8.3B | Reduce -13.1% |
| SARO Standardaero Inc. | 20.57% | 84,587,035 | $2.2B | Reduce -44.6% |
| PHAT Phathom Pharmaceuticals Inc. | 0.37% | 3,496,808 | $38.8M | No change |
| PONY Pony AI Inc. | 0.21% | 2,362,447 | $22.3M | No change |
| INVH Invitation Homes Inc. | 0.16% | 664,100 | $16.5M | No change |
| CUBE Cubesmart | 0.08% | 220,500 | $8.1M | No change |
| QTTB Q32 Bio Inc. | 0.07% | 1,102,741 | $7.1M | No change |
| GETY Getty Images Holdings Inc. | 0.05% | 6,234,252 | $4.9M | No change |
| SPRB Spruce Biosciences Inc. | 0.02% | 38,620 | $2.5M | No change |
| FWRD Forward Air Corp. | 0.02% | 107,214 | $1.8M | No change |
| ACET Adicet Bio Inc. | 0.01% | 184,295 | $1.3M | No change |
| DNUT Krispy Kreme Inc. | 0.01% | 340,748 | $1.2M | No change |
| OKUR Onkure Therapeutics Inc. Class A | 0.01% | 269,895 | $1.1M | No change |
| JSPR Jasper Therapeutics Inc. | 0.01% | 1,066,189 | $934K | No change |
| SPWR Sunpower Inc. | 0.01% | 433,158 | $550K | No change |
| HTFL Heartflow Inc. | 0.00% | 20,438 | $497K | New |
| SYRE Spyre Therapeutics Inc. | 0.00% | 9,620 | $485K | No change |
| NABL N-Able Inc. | 0.00% | 93,732 | $438K | No change |
| XCUR Exicure Inc. | 0.00% | 56,328 | $240K | No change |
| HOOD Robinhood Markets Inc. Class A | 0.00% | 3,376 | $234K | No change |
Portfolio Sells Q4 2025 → Q1 2026
Portfolio Buys Q4 2025 → Q1 2026
| HTFL Heartflow Inc. | New | 0.00% | +0.00 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 19 | $10.0B | MDLN, SARO, PHAT, INVH, PONY |
| Q1 2026 | 20 | $10.6B | MDLN, SARO, PHAT, PONY, INVH |
| Q4 2025 | 20 | $13.6B | MDLN, SARO, PHAT, PONY, INVH |
| Q3 2025 | 17 | $4.3B | SARO, PONY, PHAT, SPRB, INVH |
| Q2 2025 | 20 | $5.0B | SARO, SLNO, PHAT, PONY, INVH |
| Q1 2025 | 23 | $3.8B | SARO, SLNO, WRD, PHAT, PONY |
| Q4 2024 | 27 | $4.1B | SARO, SLNO, WRD, PONY, PHAT |
| Q3 2024 | 26 | $954.2M | QDEL, SLNO, GTM, PHAT, QTTB |
| Q2 2024 | 31 | $1.1B | QDEL, GTM, SLNO, GDS, PHAT |
| Q1 2024 | 32 | $1.6B | QDEL, GTM, SLNO, VTRU, VRNA |